Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000

Gil, Á.; Carrasco, Pilar; Jiménez, Rodrigo Martín; San-Martı́n, M.; Oyagüez, Itziar; González, Antonio

doi:10.1016/j.vaccine.2003.11.037

Cited by 57 publications

(61 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The 558.9 code is usually used to encode non-typified diarrhea at discharge, even without knowing whether these cases are infectious. Similar results on incidence categorized by age group in ARGE and non-typified AGE ( Table 1) described previously 36 suggest that many cases of non-typified AGE could be attributed to rotavirus, a hypothesis bolstered by the similarities observed in the seasonality of AGE, which is different when caused by Salmonella or Campylobacter than when due to rotavirus (Fig. 3).…”

Section: Discussionsupporting

confidence: 83%

Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain

Redondo¹,

Cano

Simón

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Rotavirus is a major burden on the Spanish Healthcare System. Rotarix Ò and RotaTeq Ò were simultaneously commercialized in Spain by February, 2007. The objective is to analyze the incidence and seasonality of rotavirus hospitalizations (RH) in Castile-La Mancha (CLM), following the first 3 y of commercialization. A cross-sectional study of the hospital discharge registry's Minimum Basic Data Set (

show abstract

Section: Discussionsupporting

confidence: 83%

Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain

Redondo¹,

Cano

Simón

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…22 Hospital discharge data have been previously shown to be an important source of information for assessing the burden of diseases such as varicella, rotavirus or pneumonia and different types of cancer. [23][24][25][26][27] All hospital discharges with a primary or secondary diagnosis of varicella (ICD-9-MC codes 052.0-052.9) during a 7-year period (2001-2007) were obtained. For each case, data were gathered on age, Region of hospitalization, type of discharge (death, recovery, other) and length of hospital stay.…”

Section: Methodsmentioning

confidence: 99%

Burden of adult varicella hospitalizations in Spain (2001-2007)

Guillen

Gil-Prieto²,

Álvaro³

et al. 2010

Human Vaccines

View full text Add to dashboard Cite

“…16 Hospital discharge data have been previously shown to be an important source of information for assessing the burden of some diseases, as varicella, rotavirus or pneumonia and different types of cancer. [17][18][19][20][21] All hospital discharges with a primary or secondary diagnosis of malignant neoplasm of the cervix (ICD-9-MC codes 180.0-180.9) or carcinoma in situ of cervix (ICD-9-MC code 233.1) during a four year period (1999-2002), were obtained. For each case data were gathered on age, Autonomous region of hospitalization, first and , first and secondary diagnosis, type of discharge (death, recovery, other) and length of hospital stay.…”

Section: Methodsmentioning

confidence: 99%

Buren of Hospital Admissions for Cervical Cancer in Spain During 1999-2002

San-Martı́n²,

R³

et al. 2007

Human Vaccines

View full text Add to dashboard Cite

Population-based retrospective epidemiological study to estimate the burden o�� to estimate the burden o�� hospitalizations by cervical cancer in Spain.� �t �as conducted by using hospital �t �as conducted by using hospital discharge data ��rom the national surveillance system ��or hospital data, Conjunto Mínimo Básico de Datos (CMBD).� Records o�� all patients admitted to hospital �ith a diagnosis o�� malignant neoplasm o�� the cervix (�CD-9-MC codes 180.�0-180.�9) or carcinoma in situ o�� cervix (�CD-9-MC code 233.�1) during a ��our year period (1999)(2000)(2001)(2002), �ere selected.� �n annual average o�� ,1�1 hospitalizations �ith a primary or secondary �n annual average o�� ,1�1 hospitalizations �ith a primary or secondary annual average o�� ,1�1 hospitalizations �ith a primary or secondary diagnosis o�� cervical cancer and 2,761 hospitalizations due to carcinoma in situ �ere identi��ied.� �nnually there �ere 2�.�� and 17.�0 hospitalizations by cervical cancer and carcinoma in situ per 100,000 �omen ≥20 years o�� age, respectively.� Hospitalization rate by cervical cancer and carcinoma in situ peaks in �omen bet�een �� and �9 years o�� age (39.�� admissions per 100,000 �omen) and 30 to �� years o�� age (32.�2 per 100,000 �omen), respectively.� The mean cost o�� a hospitalization by cervical cancer and carcinoma in situ �as €3,098 and €2,192, respectively.� The estimated annual cost o�� hospitalizations ��or cervical cancer and carcinoma in situ in Spain �as 19 million €.�

show abstract

Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000

Cited by 57 publications

References 13 publications

Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain

Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain

Burden of adult varicella hospitalizations in Spain (2001-2007)

Buren of Hospital Admissions for Cervical Cancer in Spain During 1999-2002

Contact Info

Product

Resources

About